The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Aurora Cannabis Inc (NASDAQ: ACB) was $4.69 for the day, down -5.44% from the previous closing price of $4.96. In other words, the price has decreased by -$5.44 from its previous closing price. On the day, 2.29 million shares were traded. ACB stock price reached its highest trading level at $5.04 during the session, while it also had its lowest trading level at $4.68.
Ratios:
Our analysis of ACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.07.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 265338144 and an Enterprise Value of 305776736. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 0.833 whereas that against EBITDA is -91.908.
Stock Price History:
The Beta on a monthly basis for ACB is 0.31, which has changed by 0.16159248 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $6.91, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -2.23%, while the 200-Day Moving Average is calculated to be -3.32%.
Shares Statistics:
ACB traded an average of 2.00M shares per day over the past three months and 4331980 shares per day over the past ten days. A total of 56.58M shares are outstanding, with a floating share count of 56.39M. Insiders hold about 0.55% of the company’s shares, while institutions hold 17.11% stake in the company. Shares short for ACB as of 1764288000 were 6976983 with a Short Ratio of 3.27, compared to 1761868800 on 6881094.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is $0.05, with high estimates of $0.05 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.05 and -$1.12 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is $0.11, with 3.0 analysts recommending between $0.36 and -$0.36.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 4 analysts. It ranges from a high estimate of $93.6M to a low estimate of $90.8M. As of. The current estimate, Aurora Cannabis Inc’s year-ago sales were $88.2MFor the next quarter, 4 analysts are estimating revenue of $98.95M. There is a high estimate of $103.3M for the next quarter, whereas the lowest estimate is $96.6M.
A total of 4 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $385.3M, while the lowest revenue estimate was $377M, resulting in an average revenue estimate of $379.9M. In the same quarter a year ago, actual revenue was $343.29MBased on 3 analysts’ estimates, the company’s revenue will be $400.47M in the next fiscal year. The high estimate is $410.6M and the low estimate is $384.8M.
